Fluoromethylcholine PET in recurrent multifocal hepatoma

N. P. Lenzo, J. Anderson, A. Campbell, L. Morandeau, T. R. De Grado

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has variable efficacy in evaluating hepatocellular carcinoma. We present a case of a new oncologic imaging tracer fluoromethylcholine (FCH), which has visualized recurrent multifocal hepatoma in a patient with a poor FDG avid hepatic tumour. The lesions demonstrated on FCH PET correlated well with the findings on CT hepatic angiography.

Original languageEnglish (US)
Pages (from-to)B299-B302
JournalAustralasian Radiology
Issue numberSUPPL. 4
StatePublished - Dec 2007


  • Fluorodeoxyglucose
  • Fluoromethylcholine
  • Hepatoma
  • Positronemission tomography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Fluoromethylcholine PET in recurrent multifocal hepatoma'. Together they form a unique fingerprint.

Cite this